Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR3 | P51677 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | DRD4 | P21917 | 5/20 | 0.38 |
| ▸ | DRD2 | P14416 | 4/20 | 0.38 |
| ▸ | DRD3 | P35462 | 4/20 | 0.38 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.37 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.37 |
| ▸ | SSTR5 | P35346 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6969244 | 0.93 | CHKA (0.45) | SIGMAR1KDM4EALDH1A1DRD4DRD2 | |
| SCHEMBL6976709 | 0.90 | CCR3 (0.45) | CCR3SIGMAR1KDM4EDRD4DRD2 | |
| SCHEMBL6973584 | 0.90 | SIGMAR1 (0.40) | CCR3SIGMAR1KDM4EALDH1A1DRD4 | |
| SCHEMBL6977411 | 0.89 | CCR3 (0.41) | CCR3SIGMAR1KDM4EALDH1A1DRD4 | |
| SCHEMBL6975673 | 0.86 | CYP2D6 (0.45) | CCR3KDM4EALDH1A1DRD4DRD2 | |
| SCHEMBL6967508 | 0.85 | DPP7 (0.41) | CCR3SIGMAR1KDM4EALDH1A1C5AR1 | |
| SCHEMBL6976705 | 0.85 | CHRM4 (0.42) | CCR3ALDH1A1 | |
| SCHEMBL6967328 | 0.84 | CCR3 (0.36) | CCR3SIGMAR1ALDH1A1DRD4DRD2 | |
| SCHEMBL6968225 | 0.83 | SMN1; SMN2 (0.42) | CCR3SIGMAR1ALDH1A1DRD4DRD2 | |
| SCHEMBL6968412 | 0.82 | OPRL1 (0.39) | CCR3SIGMAR1DRD4DRD2DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6566376-B1 | For therapy of chemokine receptor related diseases and conditions such as rheumatoid arthritis, chronic obstructive pulmonary disease | ASTRAZENECA UK LIMITED (GB) | 2003-05-20 | — | — | US | claimed |
| EP-1202984-B1 | DIPHENYL-PIPERIDINE DERIVATE | ASTRAZENECA UK LTD (GB) | 2003-03-05 | — | — | EP | claimed |
| US-6566376-B1 | For therapy of chemokine receptor related diseases and conditions such as rheumatoid arthritis, chronic obstructive pulmonary disease | ASTRAZENECA UK LIMITED (GB) | 2003-05-20 | — | — | US | disclosed |
| EP-1202984-B1 | DIPHENYL-PIPERIDINE DERIVATE | ASTRAZENECA UK LTD (GB) | 2003-03-05 | — | — | EP | disclosed |
| EP-1202984-A1 | NOVEL DIPHENYL-PIPERIDINE DERIVATE | AstraZeneca UK Limited (GB) | 2002-05-08 | — | — | EP | disclosed |
| WO-2001005782-A1 | NOVEL DIPHENYL-PIPERIDINE DERIVATE | ASTRAZENECA UK LIMITED (GB) | 2001-01-25 | — | — | WO | disclosed |